Aarmed Bio-Science Private Limited - Due diligence report

A 360° intelligence report on Aarmed Bio-Science Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2019-11-25 Sanand, Gujarat Active Unlisted
Share
AB Aarmed Bio-Science Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Aarmed Bio-Science Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
66/100
Trust Score
Moderate

Aarmed Bio-Science Private Limited is assessed as Moderate with a Trust Score of 66/100. Aarmed Bio-Science Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Food and Beverages sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Aarmed Bio-Science Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 2 open (12.57 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
JYOTI KUMAR AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
LALIT MALARA 01234567 Director 01/04/2018 6 yrs Approved
HARDIK SUKHWAL 01234567 Director 01/04/2018 6 yrs Approved
AAKASH UMESH ASAWA 01234567 Director 01/04/2018 6 yrs Approved
BHUPENDRA MATHURBHAI SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 55
Growth signals & trust indicators
Asset base grew 38% - capacity expansion.
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 12.57 cr already registered.
  • Compliance record supports lending.
Investor view42/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
18 Mar 2024
Director ceased
MADHU JAIN
30 Sep 2022
Director ceased
LALIT MALARA
23 Apr 2022
Director appointed
LALIT MALARA (Director)
19 Mar 2021
Charge created
Others - 5.50 cr
26 Feb 2021
Charge created
Others - 7.07 cr
25 Nov 2019
Incorporated
Registered with Roc Ahmedabad
Director appointed
JYOTI KUMAR AGRAWAL (Director)
Director appointed
HARDIK SUKHWAL (Director)
Director appointed
AAKASH UMESH ASAWA (Director)
Director appointed
BHUPENDRA MATHURBHAI SHAH (Director)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vimal Solar Private Limited U29221MH2013PTC247712 Bhusawal, Maharashtra, India
Sneakin Retail Private Limited U51909HR2022PTC105228 Panchkula, Haryana, India
Koli Impex Private Limited U51909MH2022PTC386630 Thane, Maharashtra, India
Crowddesigns U52609TN2018PTC125931 Egmore Nungambakkam, Tamil Nadu, India
Arlyn Lifesciences Private Limited U74999MH2018PTC315667 Mumbai, Maharashtra, India
Jamsons Electricals Private Limited U31909GJ2021PTC123329 Ahmadabad City, Gujarat, India
Gogad Impex Private Limited U52190RJ2008PTC027532 Pali, Rajasthan, India
Cetrama Technologies Private Limited U31909KA2021PTC155576 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Aarmed Bio-Science Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Aarmed Bio-Science Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 55/100, margin trends, ownership structure and peer set for Aarmed Bio-Science Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Aarmed Bio-Science Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Aarmed Bio-Science Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Aarmed Bio-Science Private Limited an active company?

Aarmed Bio-Science Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Aarmed Bio-Science Private Limited financially healthy?

Aarmed Bio-Science Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Aarmed Bio-Science Private Limited?

Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Aarmed Bio-Science Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Aarmed Bio-Science Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Aarmed Bio-Science Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Aarmed Bio-Science Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.